Fund comparison · from official SEC filings
IBB vs IDNA: how much do they overlap?
iShares Biotechnology ETF and iShares Genomics Immunology and Healthcare ETF
Holdings overlap24%of assets, by weight Shared positions31of 253 / 62 holdings IBB expense ratio0.44%net, per year IDNA expense ratio0.47%net, per year Shared holdings
B
BISXXBCF INSTITUTIONAL-SL AGNCY
11.65%
17.45%
V
VRTXVERTEX PHARMACEUTICALS INC
6.77%
2.96%
R
RVMDREVOLUTION MEDICINES INC
0.66%
5.70%
M
MRNAMODERNA INC
0.78%
5.22%
R
REGNREGENERON PHARMACEUTICALS
5.03%
3.10%
B
BNTXBIONTECH SE-ADR
0.55%
3.39%
E
EXELEXELIXIS INC
0.94%
3.16%
T
TWSTTWIST BIOSCIENCE CORP
0.14%
3.15%
I
INCYINCYTE CORP
1.43%
2.93%
I
IDYAIDEAYA BIOSCIENCES INC
0.19%
2.25%
I
IBRXIMMUNITYBIO INC
0.02%
2.17%
R
RCUSARCUS BIOSCIENCES INC
0.08%
1.77%
C
CRSPCRISPR THERAPEUTICS AG
0.49%
1.50%
N
NVAXNOVAVAX INC
0.11%
1.09%
I
IOVAIOVANCE BIOTHERAPEUTICS INC
0.06%
1.03%
N
NUVBNUVATION BIO INC
0.07%
0.98%
V
VIRVIR BIOTECHNOLOGY INC
0.04%
0.89%
A
ABCLABCELLERA BIOLOGICS INC
0.10%
0.88%
C
CRVSCORVUS PHARMACEUTICALS INC
0.04%
0.80%
J
JANXJANUX THERAPEUTICS INC
0.12%
0.71%
K
KURAKURA ONCOLOGY INC
0.07%
0.69%
R
RIGLRIGEL PHARMACEUTICALS INC
0.04%
0.47%
N
NTLAINTELLIA THERAPEUTICS INC
0.15%
0.47%
P
PACBPACIFIC BIOSCIENCES OF CALIF
0.03%
0.40%
D
DSGNDESIGN THERAPEUTICS INC
0.02%
0.39%
Only in IBB
G
GILDGILEAD SCIENCES INC
6.64%
A
AMGNAMGEN INC
6.63%
A
ALNYALNYLAM PHARMACEUTICALS INC
5.02%
I
IQVIQVIA HOLDINGS INC
2.81%
A
ARGXARGENX SE - ADR
2.78%
I
INSMINSMED INC
2.61%
M
MTDMETTLER-TOLEDO INTERNATIONAL
2.20%
N
NTRANATERA INC
1.87%
O
ONCBEONE MEDICINES LTD-ADR
1.86%
B
BIIBBIOGEN INC
1.80%
U
UTHRUNITED THERAPEUTICS CORP
1.61%
W
WATWATERS CORP
1.56%
I
ILMNILLUMINA INC
1.24%
G
GMABGENMAB A/S -SP ADR
1.22%
N
NBIXNEUROCRINE BIOSCIENCES INC
1.19%
M
MEDPMEDPACE HOLDINGS INC
1.02%
I
IONSIONIS PHARMACEUTICALS INC
0.91%
B
BMRNBIOMARIN PHARMACEUTICAL INC
0.90%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.81%
T
TECHBIO-TECHNE CORP
0.75%
A
ASNDASCENDIS PHARMA A/S
0.74%
H
HALOHALOZYME THERAPEUTICS INC
0.74%
B
BBIOBRIDGEBIO PHARMA INC
0.74%
T
TEMTEMPUS AI INC-CL A
0.68%
C
CRLCHARLES RIVER LABORATORIES
0.67%
Only in IDNA
I
IPSEFIPSEN
4.36%
B
BAYZFBAYER AG-REG
3.64%
T
TKPHFTAKEDA PHARMACEUTICAL CO LTD
3.51%
M
MRKMERCK & CO. INC.
3.45%
G
GLAXFGSK PLC
3.43%
R
RHHVFROCHE HOLDING AG
3.32%
S
SNYNFSANOFI
2.98%
G
GNMSFGENMAB A/S
2.63%
C
CAICARIS LIFE SCIENCES INC
2.03%
O
OPHLFONO PHARMACEUTICAL CO LTD
1.55%
2
2595GENFLEET THERAPEUTICS SHAN-H
1.00%
6
6887SUNSHINE LAKE PHARMA CO LT-H
0.52%
C
CTMXCYTOMX THERAPEUTICS INC
0.50%
O
OCGNOCUGEN INC
0.49%
1
174900ABCLON INC
0.47%
S
SGBCFSHANGHAI HENLIUS BIOTECH I-H
0.42%
I
INRLFVALNEVA SE
0.37%
V
VSTMVERASTEM INC
0.33%
2
2591GUANGZHOU INNOGEN PHARMACE-H
0.11%
M
MREOMEREO BIOPHARMA GROUP PL-ADR
0.03%
?
—GREAT BRITISH POUND
0.01%
Hold IBB and IDNA together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Other comparisons you might like
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.